Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin for Cardiorespiratory Side Effects in Retinoblastoma IAC
NCT04564521Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2020
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nitroglycerin in retinoblastoma (Rb) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Incidence of the cardio-respiratory side effects during ophthalmic artery selection and intra-arterial injection of chemotherapy agents. Status: unknown.
02
Drugs
nitroglycerin
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT04564521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04564521.